Patterns of Inheritance III and IV Flashcards
1
Q
describe X-linked SCID
A
- Caused by a defect in the γ-chain of the receptor for several different interleukins (IL2RG)
- also called the γc-cytokine receptor, since interleukins are cytokines
- If T-cells lack this receptor they cannot mature
- In turn, this results in a deficiency of normal B-cell function
2
Q
describe X-linked dominant disorders
A
- More females affected than males
- Skipping of generations NOT common
- Preponderance of females compared to males
- No male to male transmission
- Affected male transmits the diseases to ALL HIS DAUGHTERS, but none of his sons would be affected
3
Q
describe inheritance Rett Syndrome
A
- Affects females more often than males (lethal in males)
- Males die in utero or soon after birth
- Mother may have have manisfestations of the disease:
- skewed X chromosome inactivation
- disorder may be due to a germline mutation in the mother (mosaicism – confined to germline cell)
4
Q
describe incontinentia pigmenti
A
- Males with the disorder die in utero –> only females have it
- Manifests as rashes and blisters in early life
- Later, patches of hyperpigmentation “marble cake appearance” of skin
- Intellectual and learning disability (in some patients)
- Retinal detachment
- Variable expressivity in females: due to the phenomena of X-inactivation
5
Q
name the X-linked dominant disorder
A
- Vitamin D resistant Rickets (hypophosphatemic rickets)
- Retty Syndrome (lethal in males)
- Incontinentia pigmenti (lethal in males)
6
Q
go through the pedigree tree
A
7
Q
describe Y-linked inheritance
A
- Only males are affected
- Genes on Y are primarily genes involved in spermatogenesis and therefore, mutations usually cause sterility and not passed on
- Examples:
- Various mutations in the SRY genes
- H-Y histocompatability antigen
- Hairy ears
8
Q
describe incomplete penetrance
A
- May be dependent on age, especially in adult onset diseases
- Called “age dependent penetrance”
- Huntington’s disease
- Familial breast cancer
9
Q
describe variable expression
A
- In individuals who have inherited the same mutant allele, some individuals are severely affected and others are mildly affected
- 3 reasons
- random chance
- other genetic factors
- environmental exposure
10
Q
name an example of high penetrance but variable expression
A
- Neurofibromatosis type I (AD disorder)
- Some have cafe-au-lait spots, neurofibromas on the skin, bone deformities, learning disabilities
- Generally all patients with the mutant NF1 gene express at least some signs (VARIABLE expression) of the disorder (HIGH penetrance)
11
Q
name 2 examples of variable expression
A
- Iron overload disorder (hemochromatosis) (AR disorder) – more severe in males (females menstruate and lose iron)
- Xeroderma pigmentosum (AR) – more severe in individuals exposed more frequently to environmental UV radiation
- OI (AD) – Less severely affected, maybe blue sclerae in. More severely affected, maybe multiple fractures
12
Q
describe pleiotropy
A
- Disease causing mutation affects multiple organ system
- Marfan syndrome (autosomal dominant)
- Mutation in the fibrillin-1 gene
- OI
- mutation in the collagen gene
13
Q
describe locus heterogeneity
A
- Mutations at different loci that cause the same disease phenotype. Mutations of different genes cause the same disease phenotype
- OI: defect in collagen
- Mutations at different locations but = same disease
- Others:
- sensorineural hearing impairment
- Retinitis pigmentosa
- Charcot Marie Tooth disease
- SCID (AR and X-linked)
14
Q
describe allelic heterogeneity
A
- Different kinds of mutations of the same gene cause the disease
- NF-1 is caused due to a mutation in the NF-1 gene
- >1000 different mutations have been identified in the NF-1 gene
- Heterochromatosis also exhibits allelic heterogeneity due to different mutations of the HFE gene
15
Q
describe new mutations
A
- The mutation is transmitted from an unaffected parent to an affected offspring
- NO family history of the disease
- Hot spot for mutations:
- NF1
- FGFR3
- DMD (Dystrophin gene): about 1/3 of patients have new mutation